Detalles de la búsqueda
1.
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
J Clin Oncol
; 19(2): 414-9, 2001 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11208833
2.
Ultra-late recurrences of gastro-intestinal carcinoma after primary resection: the mechanism of dormancy.
Acta Gastroenterol Belg
; 76(2): 251-4, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23898565
3.
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.
Eur J Nucl Med Mol Imaging
; 35(6): 1074-80, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18219485
4.
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
Q J Nucl Med
; 45(3): 269-73, 2001 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-11788819
5.
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
Br J Haematol
; 115(2): 272-8, 2001 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11703321
6.
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Ann Oncol
; 13(9): 1356-63, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12196360
Resultados
1 -
6
de 6
1
Próxima >
>>